NCT01611415View on ClinicalTrials.gov

Drug to Drug Interaction Study With Ipragliflozin and Furosemide

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Healthy SubjectsPharmacokinetics of Ipragliflozin
Interventions
DRUG

Ipragliflozin

Oral

DRUG

Furosemide

Oral

Trial Locations (1)

LS2 9LH

Leeds

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01611415 - Drug to Drug Interaction Study With Ipragliflozin and Furosemide | Biotech Hunter | Biotech Hunter